Alireza Shoae-Hassani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alireza Shoae-Hassani has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Javad Verdi
Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
15 shared publications Shiva Sharif
Applied Cell Sciences Department, School of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences, Tehran, Iran
11 shared publicationsSeyed Abdolreza Mortazavi-Tabatabaei
Applied Cell Sciences and Tissue Engineering Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
6 shared publicationsPeyman Keyhanvar
Medical Nanotechnology Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran ; Rajaei Cardiovascular, Medical, and Research Centre, Iran University of Medical Sciences, P.O. Box 14185-615, Tehran, Iran
5 shared publicationsRashin Mohseni
Applied Cell Sciences and Tissue Engineering Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
5 shared publications- Alexander Marcus Seifalian
Nanotechnology and Regenerative Medicine Commercialization Centre (NanoRegMed Ltd.), London BioScience Innovation Centre, London NW1 0NH, UK
4 shared publications
Latest Publications
- 31 August 2026
- Published by SAGE Publications in Cellular Reprogramming
- Vol. 28 (5) , 137-142
ROCK Inhibition Accelerates Mesenchymal-to-Epithelial Transition and Improves Early Survival During Human Fibroblast Reprogramming
The low efficiency in the production of induced pluripotent stem cell (iPSC) remains a major barrier to the widespread reprogramming applications in regenerative medicine and drug screening. Small molecules that modulate key signaling pathways offer a promising approach to overcome the reprogramming limitation. Here, we demonstrated that Thiazovivin (TZV), a selective Rho-associated coiled-coil kinase inhibitor, significantly increased human fibroblast reprogramming rate by approximately 1.4-fold (* p < 0.01). Treatment with TZV during the early phase of reprogramming enhanced colony formation, improved cell survival, and promoted the mesenchymal-to-epithelial transition (MET). Quantitative Real Time Polymerase Chain Reaction (RT-PCR) analysis revealed the downregulation of mesenchymal markers (N-cadherin, 52%; vimentin, 61%; p < 0.05) and upregulation of epithelial markers (E-cadherin, 165%; EpCAM, 95%; p < 0.05). Flow cytometry confirmed elevated expression of NANOG and TRA-1-60 pluripotency markers. Collectively, these findings suggest that TZV facilitates reprogramming through MET, offering a simple and effective strategy to enhance the efficiency and scalability of human iPSC generation.
- 31 August 2026
- Published by SAGE Publications in Cellular Reprogramming
- Vol. 28 (5) , 137-142
ROCK Inhibition Accelerates Mesenchymal-to-Epithelial Transition and Improves Early Survival During Human Fibroblast Reprogramming
The low efficiency in the production of induced pluripotent stem cell (iPSC) remains a major barrier to the widespread reprogramming applications in regenerative medicine and drug screening. Small molecules that modulate key signaling pathways offer a promising approach to overcome the reprogramming limitation. Here, we demonstrated that Thiazovivin (TZV), a selective Rho-associated coiled-coil kinase inhibitor, significantly increased human fibroblast reprogramming rate by approximately 1.4-fold (* p < 0.01). Treatment with TZV during the early phase of reprogramming enhanced colony formation, improved cell survival, and promoted the mesenchymal-to-epithelial transition (MET). Quantitative Real Time Polymerase Chain Reaction (RT-PCR) analysis revealed the downregulation of mesenchymal markers (N-cadherin, 52%; vimentin, 61%; p < 0.05) and upregulation of epithelial markers (E-cadherin, 165%; EpCAM, 95%; p < 0.05). Flow cytometry confirmed elevated expression of NANOG and TRA-1-60 pluripotency markers. Collectively, these findings suggest that TZV facilitates reprogramming through MET, offering a simple and effective strategy to enhance the efficiency and scalability of human iPSC generation.
- Open Access
- 15 July 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (7) , e73176
Potential Treatment of Steroid‐Resistant Alopecia Areata Using Allogeneic Exosomes Derived From Adipose Tissue Mesenchymal Stromal Cells: A Case Report
A 31‐year‐old man with severe, corticosteroid‐resistant alopecia areata presented with substantial scalp hair loss (Severity of Alopecia Tool [SALT] score: 60%) despite a 1‐year regimen of topical corticosteroids, 5% minoxidil, and oral prednisolone. He was treated with allogeneic exosomes derived from adipose tissue mesenchymal stromal cells (ADMSCs‐Exo) at 3‐week intervals over 12 weeks (four sessions; 10 12 particles each). A cessation of hair shedding was noted after the initial session, followed by progressive regrowth that led to near‐complete hair restoration by Week 12. Treatment was accompanied by an increase in anti‐inflammatory cytokines (IL‐4, IL‐6, IL‐10) and a reduction of IFN‐γ, TNF‐α, and IL‐17 toward baseline levels. No adverse effects were reported during active treatment or throughout the 18‐week posttreatment follow‐up period. While limited to a single patient, this case suggests that ADMSC‐derived exosomes warrant further investigation as a potential cell‐free therapeutic option for refractory alopecia areata.
- 15 July 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (7) , e73176
Open AccessPotential Treatment of Steroid‐Resistant Alopecia Areata Using Allogeneic Exosomes Derived From Adipose Tissue Mesenchymal Stromal Cells: A Case Report
A 31‐year‐old man with severe, corticosteroid‐resistant alopecia areata presented with substantial scalp hair loss (Severity of Alopecia Tool [SALT] score: 60%) despite a 1‐year regimen of topical corticosteroids, 5% minoxidil, and oral prednisolone. He was treated with allogeneic exosomes derived from adipose tissue mesenchymal stromal cells (ADMSCs‐Exo) at 3‐week intervals over 12 weeks (four sessions; 10 12 particles each). A cessation of hair shedding was noted after the initial session, followed by progressive regrowth that led to near‐complete hair restoration by Week 12. Treatment was accompanied by an increase in anti‐inflammatory cytokines (IL‐4, IL‐6, IL‐10) and a reduction of IFN‐γ, TNF‐α, and IL‐17 toward baseline levels. No adverse effects were reported during active treatment or throughout the 18‐week posttreatment follow‐up period. While limited to a single patient, this case suggests that ADMSC‐derived exosomes warrant further investigation as a potential cell‐free therapeutic option for refractory alopecia areata.
- Open Access
- 10 July 2026
- Published by Springer Nature in BMC Immunology
- Vol. 27 (1)
Cetuximab combination with cytokine induced killer cells effectively inhibit conjunctival squamous cell carcinoma in vitro
We explored the potential effects of the anti-EGFR monoclonal antibody Cetuximab when combined with activated cytokine-induced killer cells (CIKs) as a novel treatment strategy for human conjunctival squamous cell carcinoma (CSCCs) in vitro. The CSCC used in our study was obtained from an explant of a patient diagnosed with the condition. After molecular and pathological confirmations, the CSCC was established as proliferating and confluent cultures and was exposed continuously for seven days to different concentrations of Cetuximab (10-3-103 µg/mL) and different ratios of CIKs. CIK cells were cultured with a high dose of IL-2 and the cell population contained activated CD3 + , CD16 + , and CD56 + cells. CIK cells alone exhibited cytotoxicity toward EGFR-positive CSCC whereas Cetuximab alone exhibited limited cytotoxic efficacy. Final counts of CSCC measured on days 1 and 7 after exposure demonstrated over 95% suppression of proliferating CSCC at a Cetuximab concentration of 102 µg/mL, with a CIKs ratio of 50:01 (Effector:Target). Meanwhile, the confluent normal limbal stem cells were largely unaffected. This particular anti-EGFR monoclonal antibody could be beneficial in treating proliferative ocular epithelial conditions, including squamous cell carcinoma of the ocular surface.
- 10 July 2026
- Published by Springer Nature in BMC Immunology
- Vol. 27 (1)
Open AccessCetuximab combination with cytokine induced killer cells effectively inhibit conjunctival squamous cell carcinoma in vitro
We explored the potential effects of the anti-EGFR monoclonal antibody Cetuximab when combined with activated cytokine-induced killer cells (CIKs) as a novel treatment strategy for human conjunctival squamous cell carcinoma (CSCCs) in vitro. The CSCC used in our study was obtained from an explant of a patient diagnosed with the condition. After molecular and pathological confirmations, the CSCC was established as proliferating and confluent cultures and was exposed continuously for seven days to different concentrations of Cetuximab (10-3-103 µg/mL) and different ratios of CIKs. CIK cells were cultured with a high dose of IL-2 and the cell population contained activated CD3 + , CD16 + , and CD56 + cells. CIK cells alone exhibited cytotoxicity toward EGFR-positive CSCC whereas Cetuximab alone exhibited limited cytotoxic efficacy. Final counts of CSCC measured on days 1 and 7 after exposure demonstrated over 95% suppression of proliferating CSCC at a Cetuximab concentration of 102 µg/mL, with a CIKs ratio of 50:01 (Effector:Target). Meanwhile, the confluent normal limbal stem cells were largely unaffected. This particular anti-EGFR monoclonal antibody could be beneficial in treating proliferative ocular epithelial conditions, including squamous cell carcinoma of the ocular surface.
- 1 September 2022
- Published by Springer Nature in Regenerative Engineering and Translational Medicine
- Vol. 8 (3) , 370-376
The Iranian National Guideline for Cell Therapy and Regenerative Medicine
- 1 September 2022
- Published by Springer Nature in Regenerative Engineering and Translational Medicine
- Vol. 8 (3) , 370-376
The Iranian National Guideline for Cell Therapy and Regenerative Medicine
- Open Access
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1)
Evaluation of Fibroblast Viability Seeded on Acellular Human Amniotic Membrane
Background. Investigating the viability and proliferative rates of fibroblast cells on human amniotic membrane (HAM) as a scaffold will be an important subject for further research. The aim of this study was to assess the fibroblast viability seeded on acellular HAM, since foreskin neonatal allogenic fibroblasts seeded on HAM accelerate the wound healing process. Methods. Fibroblasts were retrieved from the foreskin of a genetically healthy male infant, and we exploited AM of healthy term neonates to prepare the amniotic scaffold for fibroblast transfer. After cell culture, preparation of acellular HAM, and seeding of cells on HAM based on the protocol, different methods including 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT), 4 ′,6‐Diamidino‐2‐phenylindole dihydrochloride (DAPI), and propidium iodide (PI) staining were employed for assessment of fibroblast viability on HAM. Results. Based on the results obtained from the DAPI and PI staining, the percentage of viable cells in the former staining was clearly higher than that of the dead cells in the latter one. The results of DAPI and PI staining were in accordance with the findings of MTT assay, confirming that fibroblasts were viable and even proliferate on HAM. Conclusion. Our findings showed the viability of fibroblasts seeded on the acellular HAM using MTT assay, DAPI, and PI staining; however, this study had some limitations. It would be an interesting subject for future research to compare the viability and proliferation rate of fibroblasts seeded on both cellular and acellular HAM.
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1)
Open AccessEvaluation of Fibroblast Viability Seeded on Acellular Human Amniotic Membrane
Background. Investigating the viability and proliferative rates of fibroblast cells on human amniotic membrane (HAM) as a scaffold will be an important subject for further research. The aim of this study was to assess the fibroblast viability seeded on acellular HAM, since foreskin neonatal allogenic fibroblasts seeded on HAM accelerate the wound healing process. Methods. Fibroblasts were retrieved from the foreskin of a genetically healthy male infant, and we exploited AM of healthy term neonates to prepare the amniotic scaffold for fibroblast transfer. After cell culture, preparation of acellular HAM, and seeding of cells on HAM based on the protocol, different methods including 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT), 4 ′,6‐Diamidino‐2‐phenylindole dihydrochloride (DAPI), and propidium iodide (PI) staining were employed for assessment of fibroblast viability on HAM. Results. Based on the results obtained from the DAPI and PI staining, the percentage of viable cells in the former staining was clearly higher than that of the dead cells in the latter one. The results of DAPI and PI staining were in accordance with the findings of MTT assay, confirming that fibroblasts were viable and even proliferate on HAM. Conclusion. Our findings showed the viability of fibroblasts seeded on the acellular HAM using MTT assay, DAPI, and PI staining; however, this study had some limitations. It would be an interesting subject for future research to compare the viability and proliferation rate of fibroblasts seeded on both cellular and acellular HAM.
- 15 May 2020
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 133 (10)
The Lumiptosome, an engineered luminescent form of the apoptosome can report cell death by using the same Apaf-1 dependent pathway
Detection of the apoptosis signature becomes central in understanding cell death modes. We present here a whole-cell biosensor that detects Apaf-1 association and apoptosome formation using a split-luciferase complementary assay. Fusion of N-terminal (Nluc) and C-terminal (Cluc)-fragments of firefly luciferase to the N-terminus of human Apaf-1 was performed in HEK293 cells by using CRISPR-Cas9 technology. This resulted in a luminescent form of the apoptosome that we named ‘Lumiptosome’. During Apaf-1 gene editing, a high number of knock-in events were observed without selection, suggesting that the Apaf-1 locus is important for the integration of exogenous transgenes. Since activation of caspase-9 is directly dependent on the apoptosome formation, measured reconstitution of luciferase activity should result from the cooperative association of Nluc-Apaf-1 and Cluc-Apaf-1. Time-response measurements also confirmed that formation of the apoptosome occurs prior to activation of caspase-3. Additionally, overexpression of the Bcl2 apoptosis regulator in transgenic and normal HEK293 cells confirmed that formation of the Lumiptosome depends on release of cytochrome c. Thus, HEK293 cells that stably express the Lumiptosome can be utilized to screen pro- and anti-apoptotic drugs, and to examine Apaf-1-dependent cellular pathways.
- 15 May 2020
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 133 (10)
The Lumiptosome, an engineered luminescent form of the apoptosome can report cell death by using the same Apaf-1 dependent pathway
Detection of the apoptosis signature becomes central in understanding cell death modes. We present here a whole-cell biosensor that detects Apaf-1 association and apoptosome formation using a split-luciferase complementary assay. Fusion of N-terminal (Nluc) and C-terminal (Cluc)-fragments of firefly luciferase to the N-terminus of human Apaf-1 was performed in HEK293 cells by using CRISPR-Cas9 technology. This resulted in a luminescent form of the apoptosome that we named ‘Lumiptosome’. During Apaf-1 gene editing, a high number of knock-in events were observed without selection, suggesting that the Apaf-1 locus is important for the integration of exogenous transgenes. Since activation of caspase-9 is directly dependent on the apoptosome formation, measured reconstitution of luciferase activity should result from the cooperative association of Nluc-Apaf-1 and Cluc-Apaf-1. Time-response measurements also confirmed that formation of the apoptosome occurs prior to activation of caspase-3. Additionally, overexpression of the Bcl2 apoptosis regulator in transgenic and normal HEK293 cells confirmed that formation of the Lumiptosome depends on release of cytochrome c. Thus, HEK293 cells that stably express the Lumiptosome can be utilized to screen pro- and anti-apoptotic drugs, and to examine Apaf-1-dependent cellular pathways.
- 7 December 2018
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 67 (2) , 247-257
Overexpression of SMN2 Gene in Motoneuron-Like Cells Differentiated from Adipose-Derived Mesenchymal Stem Cells by Ponasterone A
Cell therapy and stem cell transplantation strategies have provided potential therapeutic approaches for the treatment of neurological disorders. Adipose-derived mesenchymal stem cells (ADMSCs) are abundant adult stem cells with low immunogenicity, which can be used for allogeneic cell replacement therapies. Differentiation of ADMSCs into acetylcholine-secreting motoneurons (MNs) is a promising treatment for MN diseases, such as spinal muscular atrophy (SMA), which is associated with the level of SMN1 gene expression. The SMN2 gene plays an important role in MN disorders, as it can somewhat compensate for the lack of SMN1 expression in SMA patients. Although the differentiation potential of ADMSCs into MNs has been previously established, overexpression of SMN2 gene in a shorter period with a longer survival has yet to be elucidated. Ponasterone A (PNA), an ecdysteroid hormone activating the PI3K/Akt pathway, was studied as a new steroid to promote SMN2 overexpression in MNs differentiated from ADMSCs. After induction with retinoic acid, sonic hedgehog, forskolin, and PNA, MN phenotypes were differentiated from ADMSCs, and immunochemical staining, specific for β-tubulin, neuron-specific enolase, and choline acetyltransferase, was performed. Also, the results of real-time PCR assay indicated nestin, Pax6, Nkx2.2, Hb9, Olig2, and SMN2 expression in the differentiated cells. After 2 weeks of treatment, cultures supplemented with PNA showed a longer survival and a 1.2-fold increase in the expression of SMN2 (an overall 5.6-fold increase; *P ≤ 0.05), as confirmed by the Western blot analysis. The PNA treatment increased the levels of ChAT, Isl1, Hb9, and Nkx2 expression in MN-like cells. Our findings highlight the role of PNA in the upregulation of SMN2 genes from MSC-derived MN-like cells, which may serve as a potential candidate in cellular therapy for SMA patients.
- 7 December 2018
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 67 (2) , 247-257
Overexpression of SMN2 Gene in Motoneuron-Like Cells Differentiated from Adipose-Derived Mesenchymal Stem Cells by Ponasterone A
Cell therapy and stem cell transplantation strategies have provided potential therapeutic approaches for the treatment of neurological disorders. Adipose-derived mesenchymal stem cells (ADMSCs) are abundant adult stem cells with low immunogenicity, which can be used for allogeneic cell replacement therapies. Differentiation of ADMSCs into acetylcholine-secreting motoneurons (MNs) is a promising treatment for MN diseases, such as spinal muscular atrophy (SMA), which is associated with the level of SMN1 gene expression. The SMN2 gene plays an important role in MN disorders, as it can somewhat compensate for the lack of SMN1 expression in SMA patients. Although the differentiation potential of ADMSCs into MNs has been previously established, overexpression of SMN2 gene in a shorter period with a longer survival has yet to be elucidated. Ponasterone A (PNA), an ecdysteroid hormone activating the PI3K/Akt pathway, was studied as a new steroid to promote SMN2 overexpression in MNs differentiated from ADMSCs. After induction with retinoic acid, sonic hedgehog, forskolin, and PNA, MN phenotypes were differentiated from ADMSCs, and immunochemical staining, specific for β-tubulin, neuron-specific enolase, and choline acetyltransferase, was performed. Also, the results of real-time PCR assay indicated nestin, Pax6, Nkx2.2, Hb9, Olig2, and SMN2 expression in the differentiated cells. After 2 weeks of treatment, cultures supplemented with PNA showed a longer survival and a 1.2-fold increase in the expression of SMN2 (an overall 5.6-fold increase; *P ≤ 0.05), as confirmed by the Western blot analysis. The PNA treatment increased the levels of ChAT, Isl1, Hb9, and Nkx2 expression in MN-like cells. Our findings highlight the role of PNA in the upregulation of SMN2 genes from MSC-derived MN-like cells, which may serve as a potential candidate in cellular therapy for SMA patients.
- Open Access
- 1 March 2018
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 24 (3) , S474
Natural Killer Cells Treated with CD11b Expressing Subpopulation of Exosomes Show Highly Activated Phenotype Against Neuroblastoma: A Future Prospect for the Treatment of High-Risk Neuroblastoma
- 1 March 2018
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 24 (3) , S474
Open AccessNatural Killer Cells Treated with CD11b Expressing Subpopulation of Exosomes Show Highly Activated Phenotype Against Neuroblastoma: A Future Prospect for the Treatment of High-Risk Neuroblastoma
- Open Access
- 7 November 2017
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 8, 1486
Natural Killer Cells from the Subcutaneous Adipose Tissue Underexpress the NKp30 and NKp44 in Obese Persons and Are Less Active against Major Histocompatibility Complex Class I Non-Expressing Neoplastic Cells
There are many types of leukocytes reside in subcutaneous adipose tissue, and among them, natural killer cells (NKs) comprise a major part. We show that the NK cells that reside in the subcutaneous adipose tissue (ADNKs) of the abdominal region found with phenotypic differences from the NKs circulating in the peripheral blood (PBNKs). In this survey flow cytometry phenotyping was used to study the differences between the natural cytotoxicity receptor expression on ADNKs and PBNKs of both obese and lean persons. Also, their cytotoxicity and cytokine production patterns were evaluated. The activation experiments on isolated and expanded NKs with IL-2, IL-15, and IL-21 cytokines revealed the main population of the CD56dim within the total ADNKs of obese persons has an under-expression of NKp30 and NKp44 despite the unchanged levels of NKG2D. The data suggest the suppressive condition of the adipose tissue niche on the NKs response against sensitive MHC-I non-expressing neoplastic cells. As the NKs are the first line of the body’s defense versus tumor formation, this change may lead to the development of transformed cells into the tumors.
- 7 November 2017
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 8, 1486
Open AccessNatural Killer Cells from the Subcutaneous Adipose Tissue Underexpress the NKp30 and NKp44 in Obese Persons and Are Less Active against Major Histocompatibility Complex Class I Non-Expressing Neoplastic Cells
There are many types of leukocytes reside in subcutaneous adipose tissue, and among them, natural killer cells (NKs) comprise a major part. We show that the NK cells that reside in the subcutaneous adipose tissue (ADNKs) of the abdominal region found with phenotypic differences from the NKs circulating in the peripheral blood (PBNKs). In this survey flow cytometry phenotyping was used to study the differences between the natural cytotoxicity receptor expression on ADNKs and PBNKs of both obese and lean persons. Also, their cytotoxicity and cytokine production patterns were evaluated. The activation experiments on isolated and expanded NKs with IL-2, IL-15, and IL-21 cytokines revealed the main population of the CD56dim within the total ADNKs of obese persons has an under-expression of NKp30 and NKp44 despite the unchanged levels of NKG2D. The data suggest the suppressive condition of the adipose tissue niche on the NKs response against sensitive MHC-I non-expressing neoplastic cells. As the NKs are the first line of the body’s defense versus tumor formation, this change may lead to the development of transformed cells into the tumors.
- 1 September 2017
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 40 (7) , 265-276
NK Cell–derived Exosomes From NK Cells Previously Exposed to Neuroblastoma Cells Augment the Antitumor Activity of Cytokine-activated NK Cells
Immune cell–derived exosomes can increase immunity against tumors. In contrast, tumor-derived exosomes can reduce the immunity and can change the tumor microenvironment to further develop and provide metastasis. These effects take place by an alteration in the innate and adaptive immune cell functions. In this experiment, we studied the natural killer (NK) cells’ effectiveness on tumor cells after expansion and thereafter incubated it with exosomes. The exosomes were derived from 2 populations of NK cells: (1) naive NK cells and, (2) NK cells previously exposed to neuroblastoma (NB) cells. Moreover, we have studied the NB-derived exosomes on NK cell function. The molecular load of the characterized exosomes (by means of nanoparticle-tracking analysis, flow cytometry, scanning electron microscopy, and western blot) from NK cells exposed to the NB cell revealed their expression of natural killer cell receptors in addition to CD56, NKG2D, and KIR2DL2 receptors. These exosomes were used to treat NK cells and thereafter administered to NB tumor cells both in vitro and in vivo. Our results showed some kind of NK cells’ education by the exosomes. This education from NK cells previously exposed to NB cell–derived exosomes caused efficient and greater cytotoxicity against NB tumors, but NB-derived exosomes act as tumor promoters by providing a tumor supporting niche. Hence, this method of preparing the exosomes has a dramatic effect on activation of anti-NK cells against NB cells.
- 1 September 2017
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 40 (7) , 265-276
NK Cell–derived Exosomes From NK Cells Previously Exposed to Neuroblastoma Cells Augment the Antitumor Activity of Cytokine-activated NK Cells
Immune cell–derived exosomes can increase immunity against tumors. In contrast, tumor-derived exosomes can reduce the immunity and can change the tumor microenvironment to further develop and provide metastasis. These effects take place by an alteration in the innate and adaptive immune cell functions. In this experiment, we studied the natural killer (NK) cells’ effectiveness on tumor cells after expansion and thereafter incubated it with exosomes. The exosomes were derived from 2 populations of NK cells: (1) naive NK cells and, (2) NK cells previously exposed to neuroblastoma (NB) cells. Moreover, we have studied the NB-derived exosomes on NK cell function. The molecular load of the characterized exosomes (by means of nanoparticle-tracking analysis, flow cytometry, scanning electron microscopy, and western blot) from NK cells exposed to the NB cell revealed their expression of natural killer cell receptors in addition to CD56, NKG2D, and KIR2DL2 receptors. These exosomes were used to treat NK cells and thereafter administered to NB tumor cells both in vitro and in vivo. Our results showed some kind of NK cells’ education by the exosomes. This education from NK cells previously exposed to NB cell–derived exosomes caused efficient and greater cytotoxicity against NB tumors, but NB-derived exosomes act as tumor promoters by providing a tumor supporting niche. Hence, this method of preparing the exosomes has a dramatic effect on activation of anti-NK cells against NB cells.